tradingkey.logo
tradingkey.logo
Search

Eli Lilly and Co

LLY
Add to Watchlist
1279.490USD
-27.200-2.08%
Market hours 10/23, 11:48(ET)
1.20TMarket Cap
45.37P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.08%

5 Days

+2.23%

1 Month

+9.35%

6 Months

+39.29%

Year to Date

+19.63%

1 Year

+58.48%

Key Figures

1301.715Open
1321.210High
351.66KVolume
45.37P/E TTM
28.50P/E Dynamic
6.230Dividend TTM
0.04%Turnover Ratio
1306.690Prev. Close
1274.640Low
452.79MTurnover
113.74P/E Static
35.55P/B
0.49%Div Yield TTM
24.54%ROA
1321.21052wk High
0.42Volume Ratio
10.59BNet Profit
941.36MShares
28.2003EPS TTM
0.52Beta
107.65%ROE
804.55652wk Low
3.56%Amplitude
85.78%Gross Margin
1.20TMarket Cap
1.64Reward/Risk
2.20%Risk Rate
Recent
Analysis
Earnings
AstraZeneca PLC Stock (AZN) Moved Up by 3.04% on Oct 22: A Full Analysis

• FDA granted accelerated approval for Ultomiris to treat primary IgA nephropathy. • AstraZeneca reports annual revenue of $58.74B and net profit of $10.22B. • Analysts issued Buy ratings with an average price target of $210.32.

TradingKey22 hours ago
Merck & Co Inc Stock (MRK) Moved Down by 3.28% on Oct 22: A Full Analysis

• Merck shares faced downward pressure from profit-taking and prominent analyst downgrades. • Investors expressed concern over upcoming quarterly earnings and Keytruda patent expiration. • Annual revenue reached $65.01B with a net profit of $18.25B.

TradingKey23 hours ago
Johnson & Johnson Stock (JNJ) Moved Up by 3.48% on Oct 22: Facts Behind the Movement

• Johnson and Johnson shares advanced following positive clinical trial data in electrophysiology. • Management raised full-year sales and adjusted earnings guidance amid solid third-quarter performance. • Institutional capital rotated into the healthcare leader, supported by strong dividend history.

TradingKey23 hours ago
Eli Lilly and Co Stock (LLY) Moved Up by 3.37% on Oct 22: What Investors Need To Know

• Analysts raised Eli Lilly targets ahead of third-quarter earnings. • Strong demand for Mounjaro and Zepbound drove momentum. • Capital investments expanded manufacturing facilities globally.

TradingKeyThu, Oct 22
Moderna Inc Stock (MRNA) Moved Up by 4.46% on Oct 21: What Investors Need To Know

• Moderna shares rose ahead of late-stage clinical trial results for intismeran autogene. • The companies are preparing regulatory submissions for United States Food and Drug Administration approval. • Moderna reported an annual revenue of $1.94 billion and a net loss.

TradingKeyWed, Oct 21
Revolution Medicines Inc Stock (RVMD) Moved Up by 7.41% on Oct 20: Facts Behind the Movement

• Revolution Medicines initiated patient treatment in new global Phase 3 clinical trials. • Analysts published bullish notes and raised price targets for the company. • The company reported zero annual revenue and a net loss of $1.13B.

TradingKeyTue, Oct 20

Eli Lilly and Co's Score

0.25vs previous score
Forecast8.30
Financial Health8.30
Technical4.11
Valuation Dimensions8.10
Institutional Confidence10.00
Risk Assessment8.98

Media Coverage

Coverage Level

49°C

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
1313.689Target Price
+4.51%Upside Space
Current Rating2026-102026-092026-082026-072026-062026-052026-042026-03
Strong Buy1010101010101111
Buy1918171718171616
Hold33666778
Sell11111110
Strong Sell00000000

Eli Lilly and Co Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Neutral

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
2026-10-29
Reporting Period
2026Q2
Earnings / Forecast
7.95/6.01
Revenue / Forecast
22.97B/20.73B

Eli Lilly and Co Profile

SectorPharmaceuticals
Ticker SymbolLLY
Number of employees47000
CountryUnited States of America

Ownership

ShareholdersProportion
Lilly Endowment, Inc.9.76%
Vanguard Capital Management, LLC5.67%
PNC Investments LLC5.43%
BlackRock Institutional Trust Company, N.A.4.44%
Shareholder TypesProportion
Investment Advisor46.65%
Investment Advisor/Hedge Fund19.18%
Foundation9.76%
Research Firm2.14%

FAQs

What is the current price of Eli Lilly and Co (LLY)?

The current price of Eli Lilly and Co (LLY) is 1306.69.

What is the symbol of Eli Lilly and Co?

The ticker symbol of Eli Lilly and Co is LLY.

What is the 52-week high of Eli Lilly and Co?

The 52-week high of Eli Lilly and Co is 1321.21.

What is the 52-week low of Eli Lilly and Co?

The 52-week low of Eli Lilly and Co is 804.56.

What is the market capitalization of Eli Lilly and Co?

The market capitalization of Eli Lilly and Co is 1.23T.

Is Eli Lilly and Co (LLY) currently rated as Buy, Hold, or Sell?

According to analysts, Eli Lilly and Co (LLY) has an overall rating of Buy, with a price target of 1313.69.

What is the Earnings Per Share (EPS TTM) of Eli Lilly and Co (LLY)?

The Earnings Per Share (EPS TTM) of Eli Lilly and Co (LLY) is 28.20.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.